ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,071.17
0.53%
US Tech 100
21,007.20
0.84%
Dow Jones
44,882.13
0.38%
Brent Oil
76.225
0.23%
Bitcoin
104,505.21
-0.22%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Entero Therapeutics Inc (ENTO) Quote

Entero Therapeutics Inc

Entero Therapeutics Inc (ENTO)

NASDAQ
0.4999
-0.0001
(-0.02%)
Closed January 31 4:00PM
Delayed by 15 minutes
0.53
0.0301
(6.02%)
After Hours: 6:58PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.53
Bid
0.52
Ask
0.53
Volume
68,931
0.4802 Day's Range 0.52215
0.185 52 Week Range 3.16
Previous Close
0.50
Open
0.4802
Last Trade
50
@
0.53
Last Trade Time
Average Volume (3m)
203,870
Financial Volume
$ 34,174
VWAP
0.495774

Ask ADVFN Intelligence (AI)

ENTO Latest News

More News

Form 8-K - Current report

January 13 2025
Edgar (US Regulatory)

Form 8-K - Current report

November 27 2024
Edgar (US Regulatory)

Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum

BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

November 14 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 13 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 13 2024
Edgar (US Regulatory)

Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Proposed merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing (i) Journey’s next-gen, first-in-class ADC-rivalling, nano-immunoconjugates (“NIC”) platform...

November 13 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

October 21 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

October 10 2024
Edgar (US Regulatory)

Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings

BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

September 10 2024
GlobeNewswire Inc.

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

August 23 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.02965.915267785770.50040.5378990.45910530.50150347CS
4-0.09-14.51612903230.620.70.3612696680.55945108CS
12-0.13-19.6969696970.660.9260.36122038700.66289796CS
26-0.1893-26.31725288470.71930.9260.1855096590.44944091CS
52-2.43-82.09459459462.963.160.1853925980.50396654CS
156-2.43-82.09459459462.963.160.1853925980.50396654CS
260-2.43-82.09459459462.963.160.1853925980.50396654CS

ENTO - Frequently Asked Questions (FAQ)

What is the current Entero Therapeutics share price?
The current share price of Entero Therapeutics is $ 0.53
What is the 1 year trading range for Entero Therapeutics share price?
Entero Therapeutics has traded in the range of $ 0.185 to $ 3.16 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FOXXFoxx Development Holdings Inc
$ 6.355
(119.90%)
33.52M
BHILBenson Hill Inc
$ 3.925
(118.06%)
13.52M
TECXTectonic Therapeutic Inc
$ 55.18
(114.54%)
5.46M
AMODAlpha Modus Holdings Inc
$ 3.2299
(109.73%)
125.47M
DOMHDominari Holdings Inc
$ 3.61
(59.03%)
4.24M
CLEUChina Liberal Education Holdings Ltd
$ 0.149
(-98.08%)
312.2M
CRGXCARGO Therapeutics Inc
$ 3.39
(-74.30%)
21.39M
TDTHTrident Digital Tech Holdings Ltd
$ 1.0159
(-58.87%)
2.46M
EVTVEnvirotech Vehicles Inc
$ 0.338202
(-49.30%)
4.79M
IRWDIronwood Pharmaceuticals Inc
$ 2.29
(-38.44%)
10.55M
NVDANVIDIA Corporation
$ 124.65
(0.77%)
394.43M
CLEUChina Liberal Education Holdings Ltd
$ 0.149
(-98.08%)
312.2M
MGOLMGO Global Inc
$ 0.1199
(17.90%)
167.92M
SPGCSacks Parente Golf Inc
$ 0.93
(57.63%)
129.47M
AMODAlpha Modus Holdings Inc
$ 3.2299
(109.73%)
126.59M

ENTO Discussion

View Posts
Tahoe2468 Tahoe2468 2 months ago
Roller coaster ride MMs just messing with this one! 
👍️0
Tahoe2468 Tahoe2468 2 months ago

ENTO >>>>
👍️0
tiger_trader tiger_trader 2 months ago
?????

https://x.com/leesmit97097126/status/1865498359072481687?s=46
👍️0
tiger_trader tiger_trader 2 months ago
What is the news on ENTO?
👍️0
glenn1919 glenn1919 2 months ago
ENTO...........................https://stockcharts.com/h-sc/ui?s=ENTO&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 months ago
ENTO........................https://stockcharts.com/h-sc/ui?s=ENTO&p=W&b=5&g=0&id=p86431144783
👍️0
conix conix 4 months ago
ENTO Chart

👍️0
glenn1919 glenn1919 5 months ago
ENTO..............................................https://stockcharts.com/h-sc/ui?s=ENTO&p=W&b=5&g=0&id=p86431144783
👍️0
gail gail 6 months ago
not in now but….

…

i see it went up some.

i grabbed some gcts. watch that one.
👍️0
TheFinalCD TheFinalCD 6 months ago
ENTO hit .33 where did you buy

I follow this youngster for BK plays

https://x.com/TyroneLopez_/status/1822995606346080494
👍️0
gail gail 6 months ago
hey glen, i assume you made this page? thx.
👍️0
gail gail 6 months ago
Im glad someone made a….

…

board for this one. i couldnt figure out how to do it.

grabbed some on the dip today. let’s do this! well, i say “let’s” but no one else is here, lol
👍️0
glenn1919 glenn1919 6 months ago
ENTO........................................https://stockcharts.com/h-sc/ui?s=ENTO&p=W&b=5&g=0&id=p86431144783
👍️0

Your Recent History

NASDAQ
ENTO
Entero Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads